PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Fairmount Funds Management LLC's Holding History (CIK: 0001802528)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 931,890 Value ($000) $32,290 Avg Close $29.29 Range $24.22 - $35.96

Q1 2024

Shares 931,890 Value ($000) $26,960 Avg Close $27.21 Range $21.43 - $33.34

Q1 2022

Shares 549,988 Value ($000) $13,024 Avg Close $28.17 Range $22.56 - $37.05

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	931,890	$32,290	$29.29	$24.22 - $35.96
Q1 2024	931,890	$26,960	$27.21	$21.43 - $33.34
Q1 2022	549,988	$13,024	$28.17	$22.56 - $37.05